Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Anthera Pharmaceuticals, Inc.

Shares of the biopharmaceutical company have fallen nearly 90 percent year-to-date. The company recently announced that that an abstract of the results from the Phase 2b PEARL-SC clinical study has been accepted as a late-breaking poster presentation at the ACR/ARHP 2012 Annual Scientific Meeting.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on